» Articles » PMID: 25483090

C/EBPα Regulates CRL4(Cdt2)-mediated Degradation of P21 in Response to UVB-induced DNA Damage to Control the G1/S Checkpoint

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2014 Dec 9
PMID 25483090
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The bZIP transcription factor, C/EBPα is highly inducible by UVB and other DNA damaging agents in keratinocytes. C/EBPα-deficient keratinocytes fail to undergo cell cycle arrest in G1 in response to UVB-induced DNA damage and mice lacking epidermal C/EBPα are highly susceptible to UVB-induced skin cancer. The mechanism through which C/EBPα regulates the cell cycle checkpoint in response to DNA damage is unknown. Here we report untreated C/EBPα-deficient keratinocytes have normal levels of the cyclin-dependent kinase inhibitor, p21, however, UVB-treated C/EBPα-deficient keratinocytes fail to up-regulate nuclear p21 protein levels despite normal up-regulation of Cdkn1a mRNA levels. UVB-treated C/EBPα-deficient keratinocytes displayed a 4-fold decrease in nuclear p21 protein half-life due to the increased proteasomal degradation of p21 via the E3 ubiquitin ligase CRL4(Cdt2). Cdt2 is the substrate recognition subunit of CRL4(Cdt2) and Cdt2 mRNA and protein levels were up-regulated in UVB-treated C/EBPα-deficient keratinocytes. Knockdown of Cdt2 restored p21 protein levels in UVB-treated C/EBPα-deficient keratinocytes. Lastly, the failure to accumulate p21 in response to UVB in C/EBPα-deficient keratinocytes resulted in decreased p21 interactions with critical cell cycle regulatory proteins, increased CDK2 activity, and inappropriate entry into S-phase. These findings reveal C/EBPα regulates G1/S cell cycle arrest in response to DNA damage via the control of CRL4(Cdt2) mediated degradation of p21.

Citing Articles

Mechanisms of Senescence and Anti-Senescence Strategies in the Skin.

Konstantinou E, Longange E, Kaya G Biology (Basel). 2024; 13(9).

PMID: 39336075 PMC: 11428750. DOI: 10.3390/biology13090647.


CRL4A degrades DNA-PKcs to modulate NHEJ repair and induce genomic instability and subsequent malignant transformation.

Feng M, Wang Y, Bi L, Zhang P, Wang H, Zhao Z Oncogene. 2021; 40(11):2096-2111.

PMID: 33627782 PMC: 7979543. DOI: 10.1038/s41388-021-01690-z.


C/EBPβ suppresses keratinocyte autonomous type 1 IFN response and p53 to increase cell survival and susceptibility to UVB-induced skin cancer.

Tam H, Hall J, Messenger Z, Jima D, House J, Linder K Carcinogenesis. 2019; 40(9):1099-1109.

PMID: 30698678 PMC: 10893916. DOI: 10.1093/carcin/bgz012.


CDT2-controlled cell cycle reentry regulates the pathogenesis of Alzheimer's disease.

Huang F, Wang M, Liu R, Wang J, Schadt E, Haroutunian V Alzheimers Dement. 2018; 15(2):217-231.

PMID: 30321504 PMC: 6758558. DOI: 10.1016/j.jalz.2018.08.013.


Induction and Validation of Cellular Senescence in Primary Human Cells.

Hernandez-Segura A, Brandenburg S, Demaria M J Vis Exp. 2018; (136).

PMID: 29985363 PMC: 6101959. DOI: 10.3791/57782.


References
1.
Jin J, Arias E, Chen J, Harper J, Walter J . A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1. Mol Cell. 2006; 23(5):709-21. DOI: 10.1016/j.molcel.2006.08.010. View

2.
Chen J, Jackson P, Kirschner M, Dutta A . Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature. 1995; 374(6520):386-8. DOI: 10.1038/374386a0. View

3.
Kall L, Canterbury J, Weston J, Noble W, MacCoss M . Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat Methods. 2007; 4(11):923-5. DOI: 10.1038/nmeth1113. View

4.
Nakagawa H, Tategu M, Yamauchi R, Sasaki K, Sekimachi S, Yoshida K . Transcriptional regulation of an evolutionary conserved intergenic region of CDT2-INTS7. PLoS One. 2008; 3(1):e1484. PMC: 2194621. DOI: 10.1371/journal.pone.0001484. View

5.
Abbas T, Sivaprasad U, Terai K, Amador V, Pagano M, Dutta A . PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev. 2008; 22(18):2496-506. PMC: 2546691. DOI: 10.1101/gad.1676108. View